Filioglou, D.; Santa-Cruz, N.; Leite, G.S.F.; Davini, D.W.; Cracchiolo, M.J.; Baker, F.L.; Husnain, M.; Simpson, R.J.; Voudouris, V.; Katsanis, E.
A Triple Oral Combination of Bendamustine, Acalabrutinib, and Venetoclax Demonstrates Efficacy Against Mantle Cell Lymphoma In Vitro and In Vivo. Cancers 2025, 17, 1889.
https://doi.org/10.3390/cancers17111889
AMA Style
Filioglou D, Santa-Cruz N, Leite GSF, Davini DW, Cracchiolo MJ, Baker FL, Husnain M, Simpson RJ, Voudouris V, Katsanis E.
A Triple Oral Combination of Bendamustine, Acalabrutinib, and Venetoclax Demonstrates Efficacy Against Mantle Cell Lymphoma In Vitro and In Vivo. Cancers. 2025; 17(11):1889.
https://doi.org/10.3390/cancers17111889
Chicago/Turabian Style
Filioglou, Dimitrios, Nina Santa-Cruz, Geovana S. F. Leite, Dan W. Davini, Megan J. Cracchiolo, Forrest L. Baker, Muhammad Husnain, Richard J. Simpson, Vasilios Voudouris, and Emmanuel Katsanis.
2025. "A Triple Oral Combination of Bendamustine, Acalabrutinib, and Venetoclax Demonstrates Efficacy Against Mantle Cell Lymphoma In Vitro and In Vivo" Cancers 17, no. 11: 1889.
https://doi.org/10.3390/cancers17111889
APA Style
Filioglou, D., Santa-Cruz, N., Leite, G. S. F., Davini, D. W., Cracchiolo, M. J., Baker, F. L., Husnain, M., Simpson, R. J., Voudouris, V., & Katsanis, E.
(2025). A Triple Oral Combination of Bendamustine, Acalabrutinib, and Venetoclax Demonstrates Efficacy Against Mantle Cell Lymphoma In Vitro and In Vivo. Cancers, 17(11), 1889.
https://doi.org/10.3390/cancers17111889
